Macnealy Hoover Investment Management Has Decreased By $321,600 Its Diebold Nxdf (DBD) Position; 683 Capital Management Increased Aldeyra Therapeutics (ALDX) Stake

683 Capital Management Llc increased Aldeyra Therapeutics Inc (ALDX) stake by 33.45% reported in 2017Q4 SEC filing. 683 Capital Management Llc acquired 279,486 shares as Aldeyra Therapeutics Inc (ALDX)’s stock rose 17.16%. The 683 Capital Management Llc holds 1.12 million shares with $31.63M value, up from 835,514 last quarter. Aldeyra Therapeutics Inc now has $143.38 million valuation. The stock decreased 7.98% or $0.65 during the last trading session, reaching $7.5. About 201,624 shares traded or 94.13% up from the average. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) has risen 55.45% since March 30, 2017 and is uptrending. It has outperformed by 43.90% the S&P500.

Macnealy Hoover Investment Management Inc decreased Diebold Nxdf Inc (DBD) stake by 21.58% reported in 2017Q4 SEC filing. Macnealy Hoover Investment Management Inc sold 20,100 shares as Diebold Nxdf Inc (DBD)’s stock declined 12.08%. The Macnealy Hoover Investment Management Inc holds 73,030 shares with $1.20M value, down from 93,130 last quarter. Diebold Nxdf Inc now has $1.17B valuation. The stock increased 7.32% or $1.05 during the last trading session, reaching $15.4. About 1.87M shares traded or 26.95% up from the average. Diebold Nixdorf, Incorporated (NYSE:DBD) has declined 50.43% since March 30, 2017 and is downtrending. It has underperformed by 61.98% the S&P500.

Since December 15, 2017, it had 2 insider buys, and 0 insider sales for $115,128 activity. FITZGERALD GALE S bought 4,000 shares worth $66,978. 3,000 shares were bought by Chapman Christopher A., worth $48,150.

Investors sentiment decreased to 1.11 in Q4 2017. Its down 0.04, from 1.15 in 2017Q3. It dived, as 21 investors sold DBD shares while 70 reduced holdings. 34 funds opened positions while 67 raised stakes. 80.71 million shares or 1.02% less from 81.54 million shares in 2017Q3 were reported. Quantbot Technology LP holds 0.02% or 13,933 shares. Ing Groep Nv invested 0% of its portfolio in Diebold Nixdorf, Incorporated (NYSE:DBD). Stratos Wealth Limited holds 0% or 227 shares in its portfolio. Tiaa Cref Invest Mgmt Limited Liability Com holds 179,672 shares or 0% of its portfolio. The New York-based Morgan Stanley has invested 0.01% in Diebold Nixdorf, Incorporated (NYSE:DBD). 12,336 were accumulated by Pnc Financial Services Grp. Southernsun Asset Limited Co reported 6.97M shares stake. Barclays Public Limited Company invested in 0% or 31,074 shares. Riverhead Capital Mgmt Ltd owns 4,270 shares for 0% of their portfolio. Schwab Charles Invest Management owns 633,114 shares. Credit Suisse Ag has 0% invested in Diebold Nixdorf, Incorporated (NYSE:DBD). Teton Advsrs owns 88,073 shares. Lpl Llc accumulated 55,107 shares. Wells Fargo And Mn holds 1.98 million shares. Catalyst Capital Advsrs has invested 0.03% in Diebold Nixdorf, Incorporated (NYSE:DBD).

Among 10 analysts covering Diebold Inc (NYSE:DBD), 6 have Buy rating, 0 Sell and 4 Hold. Therefore 60% are positive. Diebold Inc had 28 analyst reports since July 29, 2015 according to SRatingsIntel. On Tuesday, August 8 the stock rating was downgraded by J.P. Morgan to “Hold”. Credit Suisse maintained it with “Buy” rating and $3500 target in Wednesday, May 31 report. The firm has “Neutral” rating given on Monday, August 15 by JP Morgan. Wedbush maintained it with “Outperform” rating and $40 target in Thursday, February 4 report. On Tuesday, March 7 the stock rating was downgraded by Imperial Capital to “In-Line”. The firm has “Buy” rating given on Monday, June 19 by Lake Street. Imperial Capital upgraded Diebold Nixdorf, Incorporated (NYSE:DBD) on Thursday, January 19 to “Outperform” rating. JP Morgan maintained the stock with “Neutral” rating in Wednesday, November 1 report. The firm earned “Neutral” rating on Tuesday, August 8 by JP Morgan. The company was upgraded on Monday, September 26 by JP Morgan.

Analysts await Diebold Nixdorf, Incorporated (NYSE:DBD) to report earnings on May, 3. They expect $0.01 EPS, down 87.50% or $0.07 from last year’s $0.08 per share. DBD’s profit will be $759,740 for 385.00 P/E if the $0.01 EPS becomes a reality. After $0.40 actual EPS reported by Diebold Nixdorf, Incorporated for the previous quarter, Wall Street now forecasts -97.50% negative EPS growth.

683 Capital Management Llc decreased Cresud S A C I F Y A (NASDAQ:CRESY) stake by 96,896 shares to 910,286 valued at $20.11M in 2017Q4. It also reduced Blackstone Group LP (NYSE:BX) stake by 30,000 shares and now owns 170,000 shares. Procter And Gamble Co (Put) (NYSE:PG) was reduced too.

Investors sentiment decreased to 1.62 in Q4 2017. Its down 1.51, from 3.13 in 2017Q3. It dived, as 5 investors sold ALDX shares while 8 reduced holdings. 9 funds opened positions while 12 raised stakes. 9.98 million shares or 45.35% less from 18.26 million shares in 2017Q3 were reported. Deutsche Bancorporation Ag has invested 0% in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX). Hikari Power Ltd stated it has 107,858 shares. Acadian Asset Mgmt owns 5,534 shares for 0% of their portfolio. The Massachusetts-based Peddock Cap Advsrs Ltd has invested 0% in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX). Renaissance Techs Limited Co owns 0% invested in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) for 62,100 shares. Moreover, Wells Fargo & Mn has 0% invested in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX). Connecticut-based Ardsley Advisory Prtnrs has invested 0.04% in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX). Prelude Cap Limited Liability owns 1,353 shares for 0% of their portfolio. Millennium Mgmt Limited Liability Co reported 0.01% in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX). Tower Capital Limited Company (Trc) accumulated 24 shares or 0% of the stock. 12,000 are held by Drw Llc. Woodstock Corp invested in 58,243 shares or 0.07% of the stock. Private Ocean Ltd Liability Com reported 0% stake. 49,676 are held by Jpmorgan Chase & Co. 1.04 million are owned by Sphera Funds Limited.

Among 6 analysts covering Aldeyra Therapeutics Inc (NASDAQ:ALDX), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aldeyra Therapeutics Inc had 14 analyst reports since August 13, 2015 according to SRatingsIntel. The rating was initiated by Stifel Nicolaus on Friday, July 1 with “Buy”. The company was initiated on Monday, September 26 by H.C. Wainwright. The company was maintained on Thursday, June 15 by H.C. Wainwright. Cantor Fitzgerald maintained the stock with “Buy” rating in Thursday, March 29 report. Canaccord Genuity maintained the shares of ALDX in report on Wednesday, June 14 with “Buy” rating. The firm earned “Buy” rating on Thursday, September 14 by Cowen & Co. Cowen & Co maintained Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) on Wednesday, August 9 with “Buy” rating. Cantor Fitzgerald maintained the shares of ALDX in report on Thursday, November 9 with “Buy” rating. Canaccord Genuity maintained Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) on Wednesday, September 13 with “Buy” rating. H.C. Wainwright maintained it with “Buy” rating and $1800 target in Wednesday, August 9 report.

Diebold Nixdorf, Incorporated (NYSE:DBD) Institutional Positions Chart